CVS Health stock holds in the low $90s after Q2 beat
Published on 08/22/2026 at 08:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CVS Health Corp. (US1266501006) traded at $93.08 on August 22, 2026, with a market value of $118.96 billion, after a second-quarter update that showed EPS of $2.58 and revenue of $106.1 billion.
The quarter mattered because revenue rose 7.3 percent year over year and EPS topped the $1.87 estimate by $0.71, while full-year 2026 EPS guidance stayed at $7.90 to $8.10.
Results still drive the setup
Those numbers put CVS in a stronger earnings lane than the market expected, but the stock still trades below its August 22 high of $94.32 and above its low of $92.35 in the session. The gap between the quarter's $2.58 EPS and the full-year $7.90 to $8.10 target leaves investors focused on how much of the year's profit still has to come through.
Historically, the company also reported $35.1 billion of sales in the same second-quarter period, adding another anchor to the current reset in expectations.
Guidance is the key check
For CVS, the 2026 guide is now the main comparison point: EPS of $7.90 to $8.10 versus the quarter's $2.58 already booked, and total revenue that management placed above $405 billion for the year. That creates a simple test for the next updates, especially if operating income trends keep tracking ahead of the prior-quarter pace.
The same quarter produced adjusted operating income of about $5.2 billion and cash flow from operations of about $4.2 billion, which shows the business still has scale even while investors watch execution more closely.
Pharmacy and benefits
The pharmacy and benefits mix remains CVS's core engine, with health care benefits contributing nearly $36 billion of quarterly revenue and the pharmacy side generating more than $48 billion in the quarter. That split matters because it shows how much of the group's earnings power still comes from large, recurring operations rather than one-off items.
Peer comparisons also help frame the move: a market value of $118.96 billion and a P/E of 24.72 leave CVS in a very different lane from smaller managed-care names, even after a sharp earnings reset earlier this month.
Consumer angle
The representative consumer piece is the CVS Pharmacy banner, which still ties the company to prescription fill volume, front-store traffic, and health services in one network.
Shares and value
CVS Health stock was last quoted at $93.08 on August 22, 2026, with a market cap of $118.96 billion. The day's range ran from $92.35 to $94.32.
Fact box
Company: CVS Health Corp.
ISIN: US1266501006
Ticker: CVS
Exchange: NYSE
Price (as of August 22, 2026, 4:00 p.m. ET): $93.08 USD
Market cap: $118.96 billion (as of August 22, 2026)
Sector / Industry: Health Care / Health Care Services
Index membership: S&P 500
Media_Description
CVS stock and earnings chart concept
Media_Alt
CVS stock earnings summary
